Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 16:20
Evidence Synthesis
RCAN's 31.48% gross margin accelerated to, up from 9.09%.
The company's .09% marginal operating leverage accelerated to, up from .26%. RCAN's .8% revenue growth yoy decelerated, down from .3% previously. The stock's to . RCAN's .59 INR close price decelerated, down from .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 31.48 % | 9.09 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.09 % | 5.26 | ▲ |
| REVENUE_GROWTH_YOY | -1.8 % | 8.3 | ▼ |
| PRICE_CHANGE_PERCENT | -2.562 % | — | - |
| DAILY_VOLUME | 19,600 shares | 24,688 | ▼ |
| CLOSE_PRICE | 15.59 INR | 16 | ▼ |